WELCOME TO CRESTOR®
GALAXY PROGRAM!
CRESTOR®'s GALAXY program encompasses aseries of international clinical studies that, overthe years, have studied the efficacy andtolerability of ROSUVASTATIN.
WHAT IS THE GALAXY™ PROGRAM?
The GALAXY Program is a global, large-scale, comprehensive, long-term, and evolving research initiative investigatingcardiovascular risk reduction and patient outcomes with CRESTOR®.
Continue to develop current insights and address important unanswered questions in statin research by further investigating the links between optimal lipid control, atherosclerosis, cardiovascular morbidity, and mortality.
To investigate the impact of CRESTOR® on cardiovascular risk reduction and patient outcomes.
CARDIOVASCULAR RISK REDUCTION HYPOTHESES FOR THE GALAXY™ PROGRAM
WATCH VIDEOS
Welcome to CRESTOR®
Welcome to the commemoration event and honorable mention of the Crestor® brand, which due to expert research and studiesit has been possible to help and promote the health of manypeople and revolutionize the science.
Exclusive material for health professionals. Produced by AstraZeneca CAMCAR Costa Rica S.A., Roble Corporate Center, 5th floor, Escazú, San José Costa Rica,phone: (506) 2201-3400, P.O. Box: 993-1260 Escazú. www.camcar.astrazeneca.com for AstraZeneca CAMCAR S.A. To report an adverse event, quality complaints ormedical information, visit: https://www.contactazmedical.astrazeneca.com CC-11139/November 2025